The Call He Didn’t Take
In August 2020, Jonathan Benjamin had exactly 47 customers, less than $1 million in annual revenue, and a company operating in the red. He also had something most founders at that stage would gladly trade away: total ownership of his business.
Benjamin had built Unity Laundry Systems, later rebranded as UnityLab: on a simple but underserved insight: small business owners buying commercial appliances were being forced to choose between cheap consumer-grade machines that broke down quickly and expensive industrial models with opaque pricing and indifferent service. He built a direct-to-business web platform that changed that equation. The concept worked. The growth was coming. But scaling the product line required capital he didn’t have.
The conventional playbook at that moment is obvious: take a seed round, give up 20–25% of the cap table, and let a venture firm fund the next phase. Benjamin didn’t make that call. Instead, he went looking for a different kind of partner, one that wanted a share of his revenue, not a share of his company. What followed was one of the more instructive capital structure stories in the direct-to-business commerce space: a 10X growth journey built almost entirely on non-dilutive financing, culminating in a $6.6 million Series A that Benjamin was able to raise on his terms, at his timing, from a position of demonstrated strength.
According to the publicly documented case study from sagegrowthcapital.com, UnityLab’s partnership with Sage Growth Capital became the engine behind that trajectory, and the story is worth understanding in detail.
The Capital Decision: Cheap Money Is Expensive When It Costs You the Cap Table
Benjamin’s reasoning at the time was deliberate and clear. “We always knew that delaying traditional equity raises would benefit our founding team, since early-stage VC funding could prove both expensive and detrimental to the business,” he explained. “And with negative operating cash flow, traditional debt wasn’t an option.”
This is the trap most early founders don’t see until it’s too late. Venture capital is not cheap capital; it is the most expensive capital available, measured not in interest rate but in dilution and control. A seed check that buys 20% of a company that later exits at $50 million costs the founder $10 million in equity. A revenue-based financing arrangement that costs 8–12% over a 12-month payback period on a $150,000 advance costs somewhere between $12,000 and $18,000. The math is not subtle.
What Sage Growth Capital offered Benjamin was revenue-based financing (RBF), a non-dilutive structure in which the investor receives a fixed percentage of monthly revenues until a predetermined total return cap is repaid. No equity. No board seat. No warrants. No collateral beyond the company’s recurring-like revenue stream.
The initial investment was $150,000: modest by venture standards, but precisely targeted. Benjamin used it to introduce two new SKUs that addressed clear market demand on both the small-capacity and large-capacity ends of his product line. The company grew 2X from 2020 to 2021, even in the teeth of COVID-19 supply chain disruptions.
This is the first principle of intelligent leverage: small, targeted capital deployed at a moment of validated demand generates compounding returns that dilutive equity cannot match on a cost-adjusted basis.
The Outcome: An Acquisition, a Series A, and a Founder Still in the Driver’s Seat
By late 2021, UnityLab’s growth had created a new opportunity, and a new capital need. Benjamin identified Hoffman New Yorker, Inc., a legacy industrial equipment manufacturer with 24 employees and thousands of global customers, as an acquisition target that would dramatically expand UnityLab’s product range and manufacturing footprint. The problem: Hoffman wasn’t yet cash-flow positive, making traditional bank debt difficult to structure for the deal.
Benjamin returned to Sage for a second tranche; this time $750,000: to bridge the acquisition financing gap. The logic was the same as before: prove the thesis first, then raise equity from a position of strength.
It worked. The Hoffman acquisition closed in Q1 2022. UnityLab grew nearly 4X from 2021 to 2023. And in Q3 2022, Benjamin closed a $6.6 million Series A: at a valuation that reflected the business he had actually built, not the business a seed investor had bet on at a steep discount two years earlier.
The counterfactual is worth pausing on. Had Benjamin raised a VC seed round in August 2020 on $1M in revenue at a $4–5M pre-money valuation, a reasonable market-rate assumption, he would have given up roughly 20–25% of the company to fund what turned out to be less than $300,000 in actual capital need. Instead, his total cost of non-dilutive capital over that same period was a fraction of that equity value, his cap table remained clean, and he entered his Series A negotiation with four years of validated growth, an acquisition under his belt, and full founder control intact.
A May 2024 follow-on financing from Sage (used to fund international expansion into China and Italy, a 40% reduction in gross margin costs via supply chain optimization, and new product development) extended the model into UnityLab’s next chapter, again without touching the cap table ahead of future fundraising rounds.
UnityLab Is Not Alone: A Pattern Forming Across Sectors
The discipline Benjamin applied at UnityLab is appearing with increasing consistency across founder-led businesses in software, hardware, and professional services.
SafePointe, an AI-based weapons detection company founded by Greg and Timothy Holifield, used a $1 million venture debt facility from TIMIA Capital to triple its monthly recurring revenue, and was acquired by public safety technology firm SoundThinking (Nasdaq: SSTI) less than 12 months later. As Greg Holifield noted in the published case study at timiacapital.com: “When there are no warrants associated with debt, it is truly fantastic money, and much cheaper than equity.” The equity investors who came in at the same time earned 10X in nine months; TIMIA’s debt cost a fraction of that in absolute terms.
Myagi, a retail sales enablement SaaS company, used a $2.5 million non-dilutive facility from TIMIA in 2021 to grow annual recurring revenue from $2.4 million to $4.4 million, a near-doubling, before being acquired by Rallyware in 2023. Co-founder Simon Turner’s reflection, documented at timiacapital.com, is direct: “Debt is a powerful tool for capital-efficient businesses when used under the right circumstances.”
Modigi, a Salesforce-ecosystem SaaS firm, used $400,000 in revenue financing from Founderpath to hire its first sales and customer success headcount, reaching $1.7 million in ARR profitably with six employees and zero equity dilution, as detailed by founderpath.com. CEO Ken Hoppe’s framing is pointed: “It’s my own money and my co-founder’s money. Founderpath helped us keep control of the company while still getting the capital we needed to grow.”
And in Europe, German accounting software company sevdesk used a non-dilutive Growth Loan from Riverside Acceleration Capital in September 2024 to extend runway and preserve strategic optionality ahead of a planned equity raise, then was acquired by cloud management leader Cegid in 2025, with the non-dilutive bridge cited by management as a key factor in maximizing their negotiating position. The full story is documented at riverside.ac.
The Lessons: A Framework for Founders at the Capital Crossroads
Taken together, these stories form a coherent framework for any founder, operator, or family business facing a capital decision. The pattern is not about avoiding equity forever, it’s about sequencing capital intelligently so that when equity does enter the picture, it arrives at a valuation that reflects real enterprise value, not early-stage desperation pricing.
Principle 1: Cost of Capital Is Measured in Dilution, Not Interest Rate
A 12% revenue-based financing cost on a $500,000 advance is $60,000. Giving up 20% of a company that exits at $10 million is $2 million. Founders who benchmark non-dilutive financing against bank lending rates are using the wrong denominator. The right comparison is always: what does this capital cost me in equity at the most likely exit scenario?
Principle 2: Proven Growth Commands Better Equity Terms
Every quarter a founder delays a dilutive raise (and uses that time to grow revenue, validate a new product line, or complete an acquisition) is a quarter in which the equity valuation is rising. Benjamin’s Series A valuation reflected four years of demonstrated growth. A seed investor in 2020 would have priced that same company at a fraction of its 2022 worth.
Principle 3: Match the Capital Instrument to the Use Case
Revenue-based financing works when the capital deployment has a clear, near-term revenue payoff: a new SKU, a key hire, a geographic expansion, a tuck-in acquisition. It works less well for long-horizon R&D or infrastructure with a multi-year payback. Know what you’re funding before you choose the instrument.
Principle 4: Non-Dilutive Capital Creates Optionality, Equity Removes It
The most consistent theme across every case study here is the word optionality. Non-dilutive capital preserves the founder’s ability to choose: choose when to raise equity, choose whether to sell, choose to stay private. Once a VC is on your cap table with a five-to-seven-year fund cycle, the clock runs on their schedule, not yours.
Key Insights
- Non-dilutive capital is the most underutilized tool in the early-growth founder playbook. Revenue-based financing, venture debt, and growth loans allow founders to fund validated growth opportunities at a fraction of the long-run cost of equity.
- The sequencing of capital matters as much as the amount. UnityLab’s $150,000 RBF advance in 2020 directly enabled the conditions for a $6.6 million Series A in 2022, at a materially higher valuation than would have been available two years earlier.
- Acquisition financing is one of the highest-value applications of non-dilutive debt. Using revenue-based financing or venture debt to complete a tuck-in acquisition, then proving the thesis before an equity raise, is a repeatable playbook with documented outcomes.
- The "interest rate is too high" objection misunderstands the asset being protected. As SafePointe’s founder observed, when there are no warrants and no equity transfer, the all-in cost of debt is almost always lower than the cost of the equity it displaces, especially in the early and middle stages of growth.
- Exits achieved from a position of capital strength consistently outperform those driven by investor timeline pressure. Myagi, SafePointe, and sevdesk each used non-dilutive capital to control their exit timing, and the outcomes reflected that discipline.
